27Sep/13

Decks clear for Mylan's $1.6 bn purchase of Bangalore-based Agila – Indian Express


Indian Express

Decks clear for Mylan’s $1.6 bn purchase of Bangalore-based Agila
Indian Express
Generic drugmaker Mylan Inc has won U.S. antitrust approval to buy Agila, a unit of India’s Strides Arcolab Ltd, subject to divesting some products, the Federal Trade Commission said on Thursday. India’s cabinet approved the deal on September 3.
FTC Asks Mylan, Agila To Divest 11 Drugs To Approve AcquisitionNASDAQ
U.S. approves Mylan’s purchase of Bangalore-based Agila, with conditionsBusiness Standard

all 11 news articles »

27Sep/13

New Technique Could Treat Parkinson's Using Patient's Own Brain Cells – Healthline


Science Codex

New Technique Could Treat Parkinson’s Using Patient’s Own Brain Cells
Healthline
As with organ transplants, in order for a stem cell transplant to work, the donor cells must be a match for the patient receiving them. To determine a match, scientists examine a portion of the immune system called the major histocompatibility complex
Hospital begins using heart stem cells in transplant trialsFox News
Stem Cell ResearchPR-BG.com (прессъобщения) (press release)

all 35 news articles »

27Sep/13

Commercial Launch of Herceptin SC in EU Triggers Milestone Payment to … – Sacramento Bee

Commercial Launch of Herceptin SC in EU Triggers Milestone Payment to
Sacramento Bee
In February 2011, Roche began a Phase 3 registration trial of subcutaneous (SC) MabThera (rituximab), an anticancer biologic, in patients with non-Hodgkin’s lymphoma (NHL) and chronic lymphocytic leukemia (CLL) and submitted a line extension 

and more »